Peli1 impairs microglial Aβ phagocytosis through promoting C/EBPβ degradation.
Jing XuTao YuEnrica Caterina PietronigroJia YuanJessica ArioliYifei PeiXuan LuoJialin YeGabriela ConstantinChaoming MaoYi-Chuan XiaoPublished in: PLoS biology (2020)
Amyloid-β (Aβ) accumulation in the brain is a hallmark of Alzheimer's disease (AD) pathology. However, the molecular mechanism controlling microglial Aβ phagocytosis is poorly understood. Here we found that the E3 ubiquitin ligase Pellino 1 (Peli1) is induced in the microglia of AD-like five familial AD (5×FAD) mice, whose phagocytic efficiency for Aβ was then impaired, and therefore Peli1 depletion suppressed the Aβ deposition in the brains of 5×FAD mice. Mechanistic characterizations indicated that Peli1 directly targeted CCAAT/enhancer-binding protein (C/EBP)β, a major transcription factor responsible for the transcription of scavenger receptor CD36. Peli1 functioned as a direct E3 ubiquitin ligase of C/EBPβ and mediated its ubiquitination-induced degradation. Consequently, loss of Peli1 increased the protein levels of C/EBPβ and the expression of CD36 and thus, promoted the phagocytic ability in microglial cells. Together, our findings established Peli1 as a critical regulator of microglial phagocytosis and highlighted the therapeutic potential by targeting Peli1 for the treatment of microglia-mediated neurological diseases.
Keyphrases
- binding protein
- inflammatory response
- transcription factor
- neuropathic pain
- lipopolysaccharide induced
- lps induced
- high glucose
- diabetic rats
- induced apoptosis
- poor prognosis
- type diabetes
- spinal cord injury
- signaling pathway
- drug delivery
- cell death
- long non coding rna
- skeletal muscle
- white matter
- metabolic syndrome
- endothelial cells
- brain injury
- dna binding
- nk cells